UCB Future Growth
Future criteria checks 4/6
UCB is forecast to grow earnings and revenue by 26.3% and 9% per annum respectively. EPS is expected to grow by 28.4% per annum. Return on equity is forecast to be 13.3% in 3 years.
Key information
26.3%
Earnings growth rate
28.4%
EPS growth rate
Pharmaceuticals earnings growth | 14.4% |
Revenue growth rate | 9.0% |
Future return on equity | 13.3% |
Analyst coverage | Good |
Last updated | 30 Apr 2024 |
Recent future growth updates
Recent updates
Shareholders Will Probably Not Have Any Issues With UCB SA's (EBR:UCB) CEO Compensation
Apr 19Is UCB (EBR:UCB) A Risky Investment?
Mar 27Earnings Tell The Story For UCB SA (EBR:UCB) As Its Stock Soars 26%
Mar 04UCB SA's (EBR:UCB) P/E Is On The Mark
Dec 28UCB (EBR:UCB) Takes On Some Risk With Its Use Of Debt
Nov 12Is UCB (EBR:UCB) Using Too Much Debt?
Aug 07Are Investors Undervaluing UCB SA (EBR:UCB) By 48%?
Jun 02UCB's (EBR:UCB) Upcoming Dividend Will Be Larger Than Last Year's
Apr 05Does UCB (EBR:UCB) Have A Healthy Balance Sheet?
Apr 03Here's Why UCB (EBR:UCB) Can Manage Its Debt Responsibly
Dec 05These 4 Measures Indicate That UCB (EBR:UCB) Is Using Debt Reasonably Well
Sep 05Does UCB (EBR:UCB) Have A Healthy Balance Sheet?
Jun 06UCB (EBR:UCB) Is Paying Out A Larger Dividend Than Last Year
Apr 23UCB's (EBR:UCB) Upcoming Dividend Will Be Larger Than Last Year's
Apr 09UCB (EBR:UCB) Has Announced That It Will Be Increasing Its Dividend To €0.91
Mar 26Here's Why UCB (EBR:UCB) Can Manage Its Debt Responsibly
Dec 23Are Investors Undervaluing UCB SA (EBR:UCB) By 42%?
Dec 05Here's Why UCB (EBR:UCB) Can Manage Its Debt Responsibly
Sep 23UCB SA (EBR:UCB) Shares Could Be 44% Below Their Intrinsic Value Estimate
Sep 05UCB SA Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Jul 31Is UCB (EBR:UCB) A Risky Investment?
Jun 21UCB SA's (EBR:UCB) Intrinsic Value Is Potentially 96% Above Its Share Price
May 13Is UCB (EBR:UCB) Using Too Much Debt?
Mar 18Will Weakness in UCB SA's (EBR:UCB) Stock Prove Temporary Given Strong Fundamentals?
Feb 28UCB SA's (EBR:UCB) Intrinsic Value Is Potentially 54% Above Its Share Price
Feb 10What Makes UCB SA (EBR:UCB) A Great Dividend Stock?
Jan 20Is UCB SA (EBR:UCB) Popular Amongst Institutions?
Jan 07UCB (EBR:UCB) Is Growing Earnings But Are They A Good Guide?
Dec 23Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 7,029 | 1,210 | 1,687 | 1,998 | 14 |
12/31/2025 | 6,326 | 852 | 1,326 | 1,619 | 17 |
12/31/2024 | 5,615 | 407 | 969 | 1,174 | 17 |
12/31/2023 | 5,182 | 343 | 445 | 761 | N/A |
6/30/2023 | 5,111 | 332 | 620 | 975 | N/A |
3/31/2023 | 5,279 | 376 | 684 | 1,047 | N/A |
12/31/2022 | 5,447 | 420 | 748 | 1,119 | N/A |
6/30/2022 | 5,854 | 887 | 982 | 1,462 | N/A |
3/31/2022 | 5,816 | 971 | 1,021 | 1,508 | N/A |
12/31/2021 | 5,777 | 1,055 | 1,060 | 1,553 | N/A |
9/30/2021 | 5,647 | 996 | 907 | 1,371 | N/A |
6/30/2021 | 5,517 | 936 | 754 | 1,188 | N/A |
3/31/2021 | 5,432 | 834 | 743 | 1,135 | N/A |
12/31/2020 | 5,347 | 732 | 732 | 1,081 | N/A |
6/30/2020 | 5,198 | 743 | 706 | 908 | N/A |
3/31/2020 | 5,056 | 767 | 647 | 895 | N/A |
12/31/2019 | 4,913 | 790 | 588 | 882 | N/A |
6/30/2019 | 4,686 | 652 | 677 | 950 | N/A |
3/31/2019 | 4,659 | 722 | 713 | 1,020 | N/A |
12/31/2018 | 4,632 | 792 | 748 | 1,089 | N/A |
6/30/2018 | 4,569 | 872 | 711 | 1,092 | N/A |
3/31/2018 | 4,522 | 812 | 715 | 1,010 | N/A |
12/31/2017 | 4,474 | 752 | 718 | 927 | N/A |
9/30/2017 | 4,400 | 708 | N/A | N/A | N/A |
6/30/2017 | 4,325 | 664 | N/A | 780 | N/A |
3/31/2017 | 4,236 | 604 | N/A | 604 | N/A |
12/31/2016 | 4,147 | 543 | N/A | 427 | N/A |
9/30/2016 | 4,051 | 439 | N/A | N/A | N/A |
6/30/2016 | 3,955 | 334 | N/A | 66 | N/A |
3/31/2016 | 3,916 | 299 | N/A | 156 | N/A |
12/31/2015 | 3,876 | 264 | N/A | 246 | N/A |
9/30/2015 | 3,773 | 266 | N/A | 388 | N/A |
6/30/2015 | 3,670 | 268 | N/A | 530 | N/A |
3/31/2015 | 3,507 | 192 | N/A | 541 | N/A |
12/31/2014 | 3,344 | 115 | N/A | 552 | N/A |
9/30/2014 | 3,206 | 114 | N/A | 507 | N/A |
6/30/2014 | 3,067 | 112 | N/A | 462 | N/A |
3/31/2014 | 3,100 | 97 | N/A | 375 | N/A |
12/31/2013 | 3,133 | 82 | N/A | 288 | N/A |
6/30/2013 | 3,413 | 153 | N/A | 128 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: UCB's forecast earnings growth (26.3% per year) is above the savings rate (1.1%).
Earnings vs Market: UCB's earnings (26.3% per year) are forecast to grow faster than the Belgian market (15.8% per year).
High Growth Earnings: UCB's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: UCB's revenue (9% per year) is forecast to grow faster than the Belgian market (5.9% per year).
High Growth Revenue: UCB's revenue (9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: UCB's Return on Equity is forecast to be low in 3 years time (13.3%).